机构:[a]Department of Neurobiology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China老年医学科首都医科大学宣武医院[b]Department of Neurology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China神经内科老年医学科首都医科大学宣武医院[c]Key Laboratory on Neurodegenerative Disorders of Ministry of Education, Beijing, China[d]Key Laboratory on Parkinson’s Disease of Beijing, Beijing, China[e]Department of Neurology, The Affiliated Sanming First Hospital of Fujian Medical University, Sanming, Fujian, China[f]Chinese National Human Genome Center, Beijing, China[g]Parkinson’s Disease Center of Beijing Institute of Brain Disorders, Beijing, China
Variants of the MAPT gene have been suggested to be associated with Parkinson's disease (PD) and to modify the risk for leucine-rich repeat kinase 2 (LRRK2) Parkinsonism. However, this has not been confirmed in Asians with ethnicity-specific variants of MAPT and LRRK2. In this study, Asian-specific LRRK2 p. G2385R variant and IVS1 broken vertical bar 124 C>G, a functional single-nucleotide polymorphism located in the MAPT promoter region, were genotyped in 561 Chinese PD patients and 556 control subjects. Allelic and genotypic frequencies of the 2 variants were compared between cases and control subjects independently and in combination. As a result, the LRRK2 p. G2385R variant alone was associated with an increased risk for PD (Odds ratio, 1.86; 95% confidence intervals, 1.08-3.19; p = 0.014), whereas MAPT IVS1+124 C>G was not (p = 0.34). However, the coexistence of MAPT IVS1+124C>G significantly enhanced the LRRK2 G2385R-conferred risk for PD (Odds ratio, 2.30; 95% confidence intervals, 1.14-4.54; p = 0.012). These results provide further evidence supporting the interaction between MAPT and LRRK2 genes, which increases the susceptibility to PD in Chinese individuals. (C) 2014 Elsevier Inc. All rights reserved.
基金:
Ministry of Science and Technology of China [2012AA02A514]; National Basic Research Development Program of China [2011CB504101]; Ministry of Health [201002011]; Beijing High Standard Health Human Resource Cultural Program in Health System [2009e1e12]
第一作者机构:[a]Department of Neurobiology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China[b]Department of Neurology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China[c]Key Laboratory on Neurodegenerative Disorders of Ministry of Education, Beijing, China[d]Key Laboratory on Parkinson’s Disease of Beijing, Beijing, China
通讯作者:
通讯机构:[*1]Department of Neurobiology & Neurology, Xuanwu Hospital of Capital Medical University, #45 Changchun Street, 100053 Beijing, China.
推荐引用方式(GB/T 7714):
Xiaojuan Dan,Chaodong Wang,Jinghong Ma,et al.MAPT IVS1+124 C > G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals[J].NEUROBIOLOGY OF AGING.2014,35(7):1780.e7-1780.e10.doi:10.1016/j.neurobiolaging.2014.01.025.
APA:
Xiaojuan Dan,Chaodong Wang,Jinghong Ma,Xiuli Feng,Tao Wang...&Piu Chan.(2014).MAPT IVS1+124 C > G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.NEUROBIOLOGY OF AGING,35,(7)
MLA:
Xiaojuan Dan,et al."MAPT IVS1+124 C > G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals".NEUROBIOLOGY OF AGING 35..7(2014):1780.e7-1780.e10